Conditions

close

result 3254 件

JaLCDOI 10.18926/AMO/62231
FullText URL 75_3_357.pdf
Author Takabatake, Daisuke| Kajiwara, Yukiko| Ohtani, Shoichiro| Suzuki, Yoko| Yamamoto, Mari| Kubo, Shinichiro| Ikeda, Masahiko| Takahashi, Mina| Hara, Fumikata| Aogi, Kenjiro| Ohsumi, Shozo| Ogasawara, Yutaka| Nishiyama, Yoshitaka| Hikino, Hajime| Matsuoka, Kinya| Shien, Tadahiko| Taira, Naruto| Doihara, Hiroyoshi|
Abstract Perioperative dose-dense chemotherapy (DDCT) with pegfilgrastim (Peg) prophylaxis is a standard treatment for high-risk breast cancer. We explored the optimal timing of administration of 3.6 mg Peg, the dose approved in Japan. In the phase II feasibility study of DDCT (adriamycin+cyclophosphamide or epirubicin+cyclophosphamide followed by paclitaxel) for breast cancer, we investigated the feasibility, safety, neutrophil transition, and optimal timing of Peg treatment by administering Peg at days 2, 3, and 4 post-chemotherapy (P2, P3, and P4 groups, respectively). Among the 52 women enrolled, 13 were aged > 60 years. The anthracycline sequence was administered to P2 (n=33), P3 (n=5), and P4 (n=14) patients, and the taxane sequence to P2 (n=38) and P3 (n=6) patients. Both sequences showed no interaction between Peg administration timing and treatment discontinuation, treatment delay, or dose reduction. However, the relative dose intensity (RDI) was significantly different among the groups. The neutrophil count transition differed significantly among the groups receiving the anthracycline sequence. However, the neutrophil count remained in the appropriate range for both sequences in the P2 group. The timing of Peg administration did not substantially affect the feasibility or safety of DDCT. Postoperative day 2 might be the optimal timing for DDCT.
Keywords dose-dense chemotherapy breast cancer pegfilgrastim
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 357
End Page 362
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176940
Web of Science KeyUT 000667147700011
NAID 120007089828
JaLCDOI 10.18926/AMO/62227
FullText URL 75_3_323.pdf
Author Furutani, Michiyo| Yu, Zhou| Nakatsuka, Mikiya|
Abstract Gender expression is important for transgender women to improve their social passing as women. Herein, a questionnaire about the status of gender expression and support needs was distributed to 54 transgender women aged 17-71 in Japan. Most of the respondents noted that they had found it relatively difficult to handle physical changes and weight gain due to hormone treatment. They also found it difficult to enact and sustain practices such as a feminine use of voice and to use women-only services, whereas practicing and continuing with routine skin and hair care and feminine mannerisms were relatively easy for them. In the questionnaire regarding the support for gender transitioning, many items showed only a small percentage of the transgender women had received the support that they were looking for, and most of their needs for support were not addressed. Some of the factors that increased the respondents’ needs and achievement of gender expression as women included estrogen treatment, sex reassignment surgery, and living as a woman; these aspects met their support needs as well. Gender support professionals need to coordinate and collaborate with specialists in areas such as nutritional guidance and voice training to enable transgender women to improve the extent to which they can socially ‘pass’ as women.
Keywords transgender gender expression social passing as a woman real life experience gender transition
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 323
End Page 334
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176936
Web of Science KeyUT 000667147700007
NAID 120007089824
JaLCDOI 10.18926/AMO/62226
FullText URL 75_3_315.pdf
Author Wada, Riho| Fujiwara, Masaki| Yamada, Yuto| Nakaya, Naoki| Fujimori, Maiko| So, Ryuhei| Kodama, Masafumi| Higuchi, Yuji| Kakeda, Kyoko| Uchitomi, Yosuke| Yamada, Norihito| Inagaki, Masatoshi|
Abstract It is necessary to assess functional impairment when treating schizophrenia. The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) has been adopted as a measure of functional disability in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. This study was a secondary analysis from a cross-sectional study of health-related behaviors among patients with schizophrenia. We examined the validity and reliability of the Japanese version of the 12-item WHODAS 2.0 when self-administered by such patients. Participants were 350 outpatients with schizophrenia from a psychiatric hospital. The standard six-factor structure of the WHODAS 2.0 showed a good fit for these participants. The Cronbach’s alpha coefficient was 0.858, showing good internal consistency. The WHODAS 2.0 showed moderate correlations with the modified Global Assessment of Functioning and Kessler 6 scales (r=−0.434 and 0.555, respectively). The results of this study show that the Japanese version of the 12-item self-administered WHODAS 2.0 has good internal consistency and convergent validity among patients with schizophrenia. Further exploration of the usefulness of WHODAS 2.0 in clinical settings is needed.
Keywords disability schizophrenia validity reliability WHODAS 2.0
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 315
End Page 322
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176935
NAID 120007089823
JaLCDOI 10.18926/AMO/62225
FullText URL 75_3_307.pdf
Author Ishizaka, Hinata| Kuroda, Masahiro| Tekiki, Nouha| Khasawneh, Abdullah| Barham, Majd| Hamada, Kentaro| Konishi, Kohei| Sugimoto, Kohei| Katsui, Kuniaki| Sugiyama, Soichi| Watanabe, Kenta| Yoshio, Kotaro | Katayama, Norihisa| Ogata, Takeshi| Ihara, Hiroki| Oita, Masataka| Kanazawa, Susumu| Asaumi, Junichi|
Abstract Reports on irradiation dose distribution in breast cancer radiotherapy with sufficient sample size are limited in Asian patients. Elucidating dose distribution in Asian patients is particularly important as their breast volume differs compared to patients in Europe and North America. Here, we examined dose distribution in the irradiation field relative to breast volume for three irradiation methods historically used in our facility. We investigated the influence of breast volume on each irradiation method for Asian women. A total of 573 women with early-stage breast cancer were treated with breast-conserving surgery and adjuvant radiotherapy. Three methods were compared: wedge (W), field-in-field (FIF), and wedge-field-in-field (W-FIF). In patients with small breast volume, FIF decreased low- and high-dose areas within the planning target volume, and increased optimal dose area more than W. In patients with medium and large breast volumes, FIF decreased high-dose area more than W. The absolute values of correlation coefficients of breast volume to low-, optimal-, and high-dose areas and mean dose were significantly lower in FIF than in W. The correlation coefficients of V107% were 0.00 and 0.28 for FIF and W, respectively. FIF is an excellent irradiation method that is less affected by breast volume than W in Asian breast cancer patients.
Keywords breast cancer radiotherapy dose distribution irradiation method breast volume
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 307
End Page 314
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176934
Web of Science KeyUT 000667147700006
NAID 120007089838
JaLCDOI 10.18926/AMO/62221
FullText URL 75_3_299.pdf
Author Araki, Jo| Oka, Kosuke| Yamamoto, Koichiro| Hanayama, Yoshihisa | Tokumasu, Kazuki| Hagiya, Hideharu| Ogawa, Hiroko| Itoshima, Koichi| Otsuka, Fumio|
Abstract Various laboratory markers of inflammation are utilized in general practice, but their clinical diagnostic significance is often ambiguous. In the present study, we determined the clinical significance of the examination of serum levels of procalcitonin (PCT) by comparing the PCT levels with the levels of other inflammatory markers, based on a retrospective review of 332 PCT-positive patients, including cases of bacterial infection (20.5%), non-specific inflammation (20.8%), neoplasm (9.9%), connective tissue diseases (8.4%), and non-bacterial infection (7.2%), were analyzed. The serum PCT level was highest in the bacterial infection group (1.94 ng/ml) followed by the non-specific inflammatory group (0.58 ng/ml) and neoplastic diseases group (0.34 ng/ml). The serum PCT level was positively correlated with serum levels of C-reactive protein (rho=0.62), soluble interleukin-2 receptor (sIL-2R; rho=0.69), and ferritin, the plasma level of D-dimer, and white blood cell count, and negatively correlated with the serum albumin level (rho=−0.52), hemoglobin concentration, and platelet count. The serum PCT level showed a stronger positive correlation with the serum sIL-2R level than the other biomarkers. The results suggest that an increased PCT level may indicate not only an infectious state but also a non-bacterial inflammatory condition in the diagnostic process in general practice.
Keywords bacterial infection inflammation malignant lymphoma procalcitonin soluble interleukin-2 receptor
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 299
End Page 306
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176933
Web of Science KeyUT 000667147700005
NAID 120007089836
JaLCDOI 10.18926/AMO/62220
FullText URL 75_3_289.pdf
Author Miyamoto, Masakazu| Osawa, Kazuhiro| Miyoshi, Toru| Mori, Atsushi| Yoshikawa, Masaki| Oka, Takefumi| Ichikawa, Keishi| Nakamura, Kazufumi| Ito, Hiroshi|
Abstract Early treatment with an oral β-blocker is recommended in patients with a ST-segment–elevation myocardial infarction (STEMI). In this multicenter study, we evaluated the effects of a continuous administration of landiolol, an ultrashort-acting β-blocker, before primary percutaneous coronary intervention (PCI) on myocardial salvage and its safety in STEMI patients. A total of 47 Japanese patients with anterior or lateral STEMI undergoing a primary PCI within 12 h of symptom onset were randomized to receive intravenous landiolol (started at 3 μg/min/kg dose and continued to a total of 50 mg; n=23) or not (control; n=24). Patients with Killip class III or more were excluded. The primary outcome was the myocardial salvage index on cardiac magnetic resonance imaging (MRI) performed 5-7 days after the PCI. Cardiac MRI was performed in 35 patients (74%). The myocardial salvage index in the landiolol group was significantly greater than that in the control group (44.4±14.6% vs. 31.7±18.9%, respectively; p=0.04). There were no significant differences in adverse events at 24 h between the landiolol and control groups. A continuous administration of landiolol before a primary PCI may increase the degree of myocardial salvage without additional hemodynamic adverse effects within the first 24 h after STEMI.
Keywords myocardial infarction landiolol magnetic resonance imaging STEMI PCI
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 289
End Page 297
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176932
Web of Science KeyUT 000667147700004
NAID 120007089835
JaLCDOI 10.18926/AMO/62218
FullText URL 75_3_269.pdf
Author Katsui, Kuniaki| Ogata, Takeshi| Watanabe, Kenta| Yoshio, Kotaro| Kuroda, Masahiro| Hiraki, Takao| Kiura, Katsuyuki| Maeda, Yoshinobu| Toyooka, Shinichi| Kanazawa, Susumu|
Abstract Palliative concurrent chemoradiotherapy (CCRT) is often administered to patients with stage III non-small cell lung cancer (NSCLC). We investigated the clinical outcomes of patients receiving palliative CCRT for NSCLC. Data of patients with NSCLC who underwent palliative CCRT (n=16), preoperative CCRT plus surgery (n=97), or definitive CCRT (n=48) were evaluated. In all groups, the concurrent chemotherapy regimens consisted of cisplatin and docetaxel. Rates of local control (LC), distant metastasis-free survival (DMFS), progression-free survival (PFS), overall survival (OS), and prognosis were compared. The 2-year rates of LC, DMFS, PFS, and OS in 16 patients who underwent palliative CCRT were 44.4%, 12.5%, 12.5%, and 18.8%, respectively. Univariate analysis showed that palliative CCRT was associated with poor LC (p<0.001), DMFS (p<0.001), PFS (p<0.001), and OS (p<0.001) outcomes in patients who completed CCRT as a preoperative treatment and poor LC (p=0.01), DMFS (p=0.003), PFS (p=0.04), and OS (p=0.004) outcomes in patients who were considered for definitive CCRT. Although there were some long-term survivors, the clinical outcomes of palliative CCRT were significantly inferior to those of the ideal treatments. Therefore, careful determination of the appropriate treatment indications and further studies are warranted.
Keywords palliative concurrent chemoradiotherapy cisplatin/docetaxel stage III non-small cell lung cancer
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 269
End Page 277
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176930
Web of Science KeyUT 000667147700002
NAID 120007089833
JaLCDOI 10.18926/AMO/62217
FullText URL 75_3_261.pdf
Author Arapovic, Lidija Lasic| Karlovic, Zoran| Brzovic, Valentina Rajic| Bukvic, Amer| Coric, Anka| Vukojevic, Katarina| Verzak, Zeljko|
Abstract We conducted a retrospective analysis of records of special needs patients (SNPs) who received dental treatment under orotracheal-intubation general anaesthesia (OIGA) at Caritas Centre St. Family in Mostar, Bosnia and Herzegovina during the 14-year period from January 2005 to December 2018. Of the 7,085 SNPs who received dental treatment, 1,220 (17.2%) received dental treatment under OIGA: 829 (67.9%) males and 391 (32.1%) females. The patients’ mean age was 18.3±10.9 years (747 paediatric and 473 adult patients). Mental retardation and psychiatric problems were the most common medical conditions (81.22%). The most common indication for dental treatment under OIGA was behaviour management (87.21%), and 81% of the patients had an urgent need for treatment. Many of the patients had restorative treatment (3,833) and tooth extractions (3,681). From 2011 onwards, the number of tooth extractions decreased significantly. Annual trends revealed a rapid increase of patients every year. The mean dental treatment duration was 95.3±12.1 min; the mean time under OIGA was 98±8.5 min. No serious adverse effects occurred. There was increase of annual trend of SNP in OIGA. The number of extractions decreased while the number of preventive and restorative dental treatments increased.
Keywords special needs patients general anaesthesia dental treatment dental care mental retardation
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2021-06
Volume volume75
Issue issue3
Publisher Okayama University Medical School
Start Page 261
End Page 268
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders CopyrightⒸ 2021 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 34176929
Web of Science KeyUT 000667147700001
NAID 120007089832
FullText URL fulltext.pdf
Author He, Fang| Matsumoto, Yoshinori| Asano, Yosuke| Yamamura, Yuriko| Katsuyama, Takayuki| La Rose, Jose| Tomonobu, Nahoko| Komalasari, Ni Luh Gede Yoni| Sakaguchi, Masakiyo| Rottapel, Robert| Wada, Jun|
Keywords ABL Abelson murine leukemia viral oncogene homolog Runx2 (runt-related transcription factor 2) tyrosine phosphorylation invasion
Note Erratum in https://ousar.lib.okayama-u.ac.jp/62331|
Published Date 2021-05-31
Publication Title Frontiers In Oncology
Volume volume11
Publisher Frontiers Media S.A.
Start Page 665273
ISSN 2234-943X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 He, Matsumoto, Asano, Yamamura, Katsuyama, La Rose, Tomonobu, Komalasari, Sakaguchi, Rottapel and Wada.
File Version publisher
PubMed ID 34136397
DOI 10.3389/fonc.2021.665273
NAID 120007089841
Web of Science KeyUT 000661158800001
Related Url isVersionOf https://doi.org/10.3389/fonc.2021.665273
FullText URL fulltext.pdf
Author Kuroda, Kosuke| Ishii, Kenzo| Mihara, Yuko| Kawanoue, Naoya| Wake, Hidenori| Mori, Shuji| Yoshida, Michihiro| Nishibori, Masahiro| Morimatsu, Hiroshi|
Published Date 2021-05-13
Publication Title Scientific Reports
Volume volume11
Issue issue1
Publisher Nature Research
Start Page 10223
ISSN 2045-2322
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2021
File Version publisher
PubMed ID 33986340
DOI 10.1038/s41598-021-89555-z
NAID 120007053368
Web of Science KeyUT 000656946100013
Related Url isVersionOf https://doi.org/10.1038/s41598-021-89555-z
FullText URL fulltext.pdf
Author Mise, Koki| Imamura, Mariko| Yamaguchi, Satoshi| Watanabe, Mayu| Higuchi, Chigusa| Katayama, Akihiro| Miyamoto, Satoshi| Uchida, Haruhito A.| Nakatsuka, Atsuko| Eguchi, Jun| Hida, Kazuyuki| Nakato, Tatsuaki| Tone, Atsuhito| Teshigawara, Sanae| Matsuoka, Takashi| Kamei, Shinji| Murakami, Kazutoshi| Shimizu, Ikki| Miyashita, Katsuhiro| Ando, Shinichiro| Nunoue, Tomokazu| Yoshida, Michihiro| Yamada, Masao| Shikata, Kenichi| Wada, Jun|
Keywords cardiovascular event diabetes lectins N-glycans urinary biomarkers
Published Date 2021-05-24
Publication Title Frontiers In Cardiovascular Medicine
Volume volume8
Publisher Frontiers Media SA
Start Page 668059
ISSN 2297-055X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 by the authors.
File Version publisher
PubMed ID 34109226
DOI 10.3389/fcvm.2021.668059
NAID 120007053373
Web of Science KeyUT 000658156400001
Related Url isVersionOf https://doi.org/10.3389/fcvm.2021.668059
FullText URL fulltext.pdf
Author Doi, Toshihisa|
Keywords mental model design model user model usability subjective comprehension GUI
Published Date 2021-05-03
Publication Title Symmetry-Basel
Volume volume13
Issue issue5
Publisher MDPI
Start Page 795
ISSN 2073-8994
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 by the author.
File Version publisher
DOI 10.3390/sym13050795
NAID 120007053372
Web of Science KeyUT 000654577200001
Related Url isVersionOf https://doi.org/10.3390/sym13050795
FullText URL fulltext.pdf
Author Omori, Toshinori| Tazawa, Hiroshi| Yamakawa, Yasuaki| Osaki, Shuhei| Hasei, Joe| Sugiu, Kazuhisa| Komatsubara, Tadashi| Fujiwara, Tomohiro| Yoshida, Aki| Kunisada, Toshiyuki| Urata, Yasuo| Kagawa, Shunsuke| Ozaki, Toshifumi| Fujiwara, Toshiyoshi|
Keywords Gastric yolk sac Tumor-like carcinoma Adenocarcinoma; Alpha-fetoprotein
Published Date 2021-04-22
Publication Title PLoS ONE
Volume volume16
Issue issue4
Publisher Public Library Science
Start Page e0250643
ISSN 1932-6203
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2021 Omori et al.
File Version publisher
PubMed ID 33886686
DOI 10.1371/journal.pone.0250643
NAID 120007045007
Web of Science KeyUT 000644138300019
Related Url isVersionOf https://doi.org/10.1371/journal.pone.0250643
FullText URL fulltext20210607-1.pdf
Author Yamashita, Koichiro| Sundaram, Prathima| Uchida, Tetsuya| Matsuo, Toshihiko| Wong, Willy|
Keywords retinal prosthesis photoelectric dye boundary value problem biophysical models of retinal cells
Note This is the Accepted Manuscript version of an article accepted for publication in Journal of Neural Engineering. IOP Publishing Ltd is not responsible for any errors or omissions in this version of the manuscript or any version derived from it. The Version of Record is available online at https://doi.org/10.1088/1741-2552/abf892. |
Published Date 2021-5-5
Publication Title Journal of Neural Engineering
Volume volume18
Issue issue4
Publisher IOP Publishing
Start Page 045006
ISSN 1741-2560
NCID AA12157399
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
File Version author
PubMed ID 33857924
DOI 10.1088/1741-2552/abf892
Web of Science KeyUT 000648710500001
Related Url isVersionOf https://doi.org/10.1088/1741-2552/abf892
FullText URL K0006389_abstract_review.pdf K0006389_fulltext.pdf K0006389_summary.pdf
Author Nakamura, Tomoya|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6389号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Dental Science
Grantor 岡山大学
language English
Copyright Holders © Nakamuraet al.
FullText URL K0006388_abstract_review.pdf K0006388_summary.pdf K0006388_fulltext.pdf
Author Saho, Hikari|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6388号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Dental Science
Grantor 岡山大学
language English
FullText URL K0006375_fulltext.pdf K0006375_abstract_review.pdf K0006375_summary.pdf
Author Mikai, Akihiro|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6375号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Dental Science
Grantor 岡山大学
language English
FullText URL K0006372_fulltext.pdf K0006372_abstract_review.pdf K0006372_summary.pdf
Author Aung, Kyaw Thu|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6372号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Dental Science
Grantor 岡山大学
language English
Copyright Holders © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
FullText URL K0006354_abstract_review.pdf K0006354_fulltext.pdf K0006354_summary.pdf
Author Kobayashi, Yasuyuki|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6354号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
FullText URL K0006351_abstract_review.pdf K0006351_fulltext.pdf K0006351_summary.pdf
Author Taira, Yuki|
Published Date 2021-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6351号
Granted Date 2021-03-25
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English